Polifeprosan 20

DB16298InvestigationalSmall molecule

Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating Patients With Brain Metastases).

Also known as
Polifeprosan
Code names
PCPP-SA (20:80)

Resolves to

Compound
UNIIS40C40DA21CAS90409-78-2
Clinical / RWD
RxNorm1426339

What you can answer from here — as of April 23, 2025

6Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Polifeprosan 20, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In